Avacta Life Sciences Ltd. is a biotechnology company that develops safe and efficacious drugs, and high performing diagnostics based on its proprietary Affimer® and pre|CISION™ platforms. Avacta’s therapeutics division develops novel cancer immunotherapies and its diagnostics division develops high performing diagnostics as well as works with partners world-wide to develop Affimer reagents.